SPIE Shares Drop 2% and Test Their MM200, Last Stand at €47.42

A Decline that Positions the Stock Below its Short and Medium Moving Averages

SPIE shares have fallen 2.1% to €47.58, down from €48.60 at the previous close. The stock thus extends its correction for the quarter and now shows a decline of 4.65% over the month, while the CAC 40 is down 0.42% and the SBF 120 is down 0.45% during the session. The movement occurs in a cautious European environment, as Brent crude rises about 2% to $86 amid renewed tensions around the Strait of Hormuz, and comments from Fed Governor Lisa Cook, ready to act if inflation does not slow down, weigh on risk appetite.

From a chart perspective, the price has moved below its MM20 at €49.14 (a gap of -3.17%) and its MM50 at €48.68 (a gap of -2.26%), while remaining in contact with its MM200 at €47.42. The RSI at 60 remains in the neutral zone, without any excess signal, indicating a gradual erosion rather than a sharp drop.

A Support at €46.56 in Sight After a Month of Correction

Today's slide extends the decline that began in early July, when the stock had already tested its 20-day moving average. The €46.56 zone now represents the first support threshold in the near term, about 2% below the current price. Crossing below the MM200, which has often served as a floor during correction phases since spring, would open a new technical context.

The group remains active on the external growth front, with the acquisition of Nimeg AG announced in early July to strengthen its life sciences division. Over twelve months, the performance is still positive at 2.06%. The next observable benchmark: whether or not the MM200 at €47.42 holds.